17th October

17 October

Business to Business meetings and other main event activities

Venue: Molo IV - Corso Camillo Benso Conte di Cavour 3, 34132 Trieste, Italy.

09:30 – 14:00

Business to business meetings in the main event Meet in Italy for Life Sciences 2, location: Molo IV - Corso Camillo Benso Conte di Cavour 3, 34132 Trieste, Italy.

Important note! To participate in the B2B meetings is required registration with the main event. Please register at this link: https://trieste2019.mit4ls.b2match.io/

14:30 – 18:00

UTILE Pitching Academy

Venue: NH Hotel Trieste Corso Cavour 7, 34132 Trieste – Italy (opposite to the building for B2B meetings)

14:00 – 14:30

Welcome address and introduction to the program 

14:30 – 18:30

16:00 – 16:30

Coffee break

UTILE Pitching Academy (Briefing, Pitching sessions, One2One meeting with coaches)

Speakers: up to 8 CEOs from UTILE companies and projects who will present their slide deck; coaches and mentors

18th  October

18th October

UTILE Workshop Valorisation of Research Results from Healthcare Projects

Venue: NH Hotel Trieste Corso Cavour 7, 34132 Trieste – Italy

09:00 – 09:15

Welcome and introduction of Workshop objectives and speakers

09:15 – 10:15

Business Development and Partnering with Industry - how small companies in the life sciences can engage with large firms

Mark Wilson, Strategic Technology Bioconsulting

10:15 – 11:15

Understanding and Raising Venture Capital in Health-Tech Context

Teresa Cunha, Tech Tour

11:15 – 11:45

 Coffee Break

11:45 – 12:30

How to accelerate the introduction of meaningful innovations in life sciences (Public Funding)

Eleanor Dawson, ttopstart

12:30 – 13:30

Lunch

13:30 – 15:00

UTILE Pitching Session

Moderator:

Mark Wilson, Strategic Technology Bioconsulting

Expert Jury:

Davide Turco, Indaco Venture Partners

Simone Zanolo, Indaco Venture Partners

Teresa Cunha, MT Consulting

Presenting Companies:

Michele Marzola, Surgica Robotica

Diego Dolcetta, VivacSo srl

Yulia Sidorova, GeneCode Ltd 

Andrea Tortori, Bioridis Srl

Suzy Scholl, Institut Curie Department of drug development and innovation